Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|September 28, 2020
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast CancerKatia Khoury, Antoinette R Tan, Andrew Elliott, et al.
Oncotarget|June 8, 2017
BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutationsSafoora Deihimi, Avital Lev, Michael Slifker, et al.
Translational Oncology|January 19, 2021
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor typeJim Abraham, Amy B Heimberger, John Marshall, et al.
Cancer Research Communications|January 29, 2024
Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor MutagenicityShreya M Shah, Elena V Demidova, Salena Ringenbach, et al.
JCO Precision Oncology|September 7, 2023
Opposing Roles of SPOP Mutations in Human Prostate and Endometrial CancersLudimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, et al.
Research Square|January 18, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancerMidhun Malla, Sachin Kumar Deshkmukh, Sharon Wu, et al.
Neuro-Oncology|July 3, 2016
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignanciesSarah T Garber, Yuuri Hashimoto, Shiao-Pei Weathers, et al.
Gynecologic Oncology Reports|October 13, 2025
Impact of molecular and immune signature on endometrial biopsies with atypical hyperplasia with and without concurrent endometroid carcinomaTerrence Wong, Joellen Fresia, Nicholas Adzibolosu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck CancerAlexander Y Deneka, Yasmine Baca, Ilya G Serebriiskii, et al.
JCO Precision Oncology|June 20, 2025
Molecular Correlates of Long-Term Response to Bevacizumab in GlioblastomaJohn L Villano, Catherine R Garcia, Rachael M Morgan, et al.
Pageof 17